Biohaven’s Nurtec.com achieved the highest traffic across branded migraine patient sites in the US from July 2021 to June 2022, followed by Eli Lilly’s Emgality.com and Allergan’s Botoxchronicmigraine.com. The highest proportion of traffic to these sites originated from direct sources, followed by referrals and organic traffic. Websites for several brands, including Emgality, Vyepti, Botox, and Nurtec, had similar levels of high direct traffic, while Amgen’s Aimovig.com had the lowest.

For patient branded sites, Lundbeck spent the most on digital display advertising (DDA) for Vyepti.com, followed by Allergan’s Botoxchronicmigraine.com. Nurtec.com was supported by the most paid keywords by a large margin, followed by Aimovig.com.